Year: 2017

The Trump Administration and the Effect on the 340B Drug Program

The 340B Drug Program may experience some changes due to the new administration and Republican congress. Some anticipate that drug manufacturers interests will be addressed rather than the concerns of health plans or providers. Whether this is true has yet

Posted in 340B Program Tagged with: , , ,